MedTrace Logo

Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

NCT05279833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87810

Last updated 2024-01-09

No results posted yet for this study

Summary

A systematic literature review (SLR) will be conducted to understand the landscape of evidence on the relative safety and effectiveness/efficacy of dronedarone compared to sotalol in patients with AFib within interventional clinical trials and observational studies.

Conditions

Interventions

DRUG

dronedarone

Pharmaceutical form is tablet and route of administration is oral

DRUG

sotalol

Pharmaceutical form is tablet and route of administration is oral

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences and Operations · Sanofi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-24
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05279833 on ClinicalTrials.gov